325 related articles for article (PubMed ID: 21994713)
1. Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.
Vetrini F; Ng P
Viruses; 2010 Sep; 2(9):1886-1917. PubMed ID: 21994713
[TBL] [Abstract][Full Text] [Related]
2. Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.
Piccolo P; Brunetti-Pierri N
Biomedicines; 2014 Apr; 2(2):132-148. PubMed ID: 28548064
[TBL] [Abstract][Full Text] [Related]
3. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
Parks R; Evelegh C; Graham F
Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.
Brunetti-Pierri N; Ng P
Virus Genes; 2017 Oct; 53(5):684-691. PubMed ID: 28593513
[TBL] [Abstract][Full Text] [Related]
5. Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges.
Vetrini F; Ng P
Curr Pharm Des; 2011; 17(24):2488-99. PubMed ID: 21774769
[TBL] [Abstract][Full Text] [Related]
6. Progress towards liver and lung-directed gene therapy with helper-dependent adenoviral vectors.
Brunetti-Pierri N; Ng P
Curr Gene Ther; 2009 Oct; 9(5):329-40. PubMed ID: 19860648
[TBL] [Abstract][Full Text] [Related]
7. Helper-dependent adenoviral vectors for liver-directed gene therapy.
Brunetti-Pierri N; Ng P
Hum Mol Genet; 2011 Apr; 20(R1):R7-13. PubMed ID: 21470977
[TBL] [Abstract][Full Text] [Related]
8. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.
Seiler MP; Cerullo V; Lee B
Curr Gene Ther; 2007 Oct; 7(5):297-305. PubMed ID: 17979676
[TBL] [Abstract][Full Text] [Related]
9. Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors.
Shi CX; Hitt M; Ng P; Graham FL
Hum Gene Ther; 2002 Jan; 13(2):211-24. PubMed ID: 11812278
[TBL] [Abstract][Full Text] [Related]
10. Improvements in gene therapy: averting the immune response to adenoviral vectors.
Ritter T; Lehmann M; Volk HD
BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
[TBL] [Abstract][Full Text] [Related]
11. [Advances in helper-dependent adenoviral vector--a review review].
Fu Y; He J; Shi C; Hong T
Wei Sheng Wu Xue Bao; 2009 Feb; 49(2):147-52. PubMed ID: 19445167
[TBL] [Abstract][Full Text] [Related]
12. MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus.
Suzuki M; Cerullo V; Bertin TK; Cela R; Clarke C; Guenther M; Brunetti-Pierri N; Lee B
Hum Gene Ther; 2010 Mar; 21(3):325-36. PubMed ID: 19824822
[TBL] [Abstract][Full Text] [Related]
13. HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy.
Rosewell Shaw A; Porter C; Biegert G; Jatta L; Suzuki M
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681750
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy.
Farzad L; Cerullo V; Yagyu S; Bertin T; Hemminki A; Rooney C; Lee B; Suzuki M
Mol Ther Oncolytics; 2014; 1():14008. PubMed ID: 27119096
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral vectors for gene replacement therapy.
Cao H; Koehler DR; Hu J
Viral Immunol; 2004; 17(3):327-33. PubMed ID: 15357899
[TBL] [Abstract][Full Text] [Related]
16. The role of chromatin in adenoviral vector function.
Wong CM; McFall ER; Burns JK; Parks RJ
Viruses; 2013 Jun; 5(6):1500-15. PubMed ID: 23771241
[TBL] [Abstract][Full Text] [Related]
17. Advances in helper-dependent adenoviral vector research.
Segura MM; Alba R; Bosch A; Chillón M
Curr Gene Ther; 2008 Aug; 8(4):222-35. PubMed ID: 18691018
[TBL] [Abstract][Full Text] [Related]
18. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.
Morral N; O'Neal W; Rice K; Leland M; Kaplan J; Piedra PA; Zhou H; Parks RJ; Velji R; Aguilar-Córdova E; Wadsworth S; Graham FL; Kochanek S; Carey KD; Beaudet AL
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12816-21. PubMed ID: 10536005
[TBL] [Abstract][Full Text] [Related]
19. Helper virus-mediated downregulation of transgene expression permits production of recalcitrant helper-dependent adenoviral vector.
Palmer DJ; Grove NC; Ng P
Mol Ther Methods Clin Dev; 2016; 3():16039. PubMed ID: 27331077
[TBL] [Abstract][Full Text] [Related]
20. Helper-dependent adenoviral vectors for gene therapy.
Palmer DJ; Ng P
Hum Gene Ther; 2005 Jan; 16(1):1-16. PubMed ID: 15703484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
